AI is about to change healthcare. These 8 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
To own Alkane, you have to be comfortable with a mid-tier miner that is now trying to balance reinvestment in growth projects with returning cash to shareholders. The FY26 result, with production at the upper end of guidance, record cash flow and a proposed fully franked A$0.02 dividend, reinforces that shift and modestly alters the near term catalysts: execution on FY27 production and cost guidance, and the effectiveness of ongoing exploration at Björkdal and the Northern Molong Porphyry Project. The recent share price pullback despite these updates suggests the market is still weighing integration risk from Mandalay, a relatively new board and the capital allocation mix between growth capex and dividends. The news itself does not remove those risks, but it does sharpen the focus on delivery.
However, one emerging concern is how sustainable this new dividend might be if conditions tighten. Despite retreating, Alkane Resources' shares might still be trading above their fair value and there could be some more downside. Discover how much.Four Simply Wall St Community fair value estimates span roughly A$2.02 to A$12.76 per share, underlining how differently private investors view Alkane’s potential. Set against the company’s recent move toward dividends and its reliance on successful exploration and disciplined costs, this spread of views gives you a sense of how strongly perceptions of risk and reward can diverge and why it can be useful to compare several independent takes on the story.
Explore 4 other fair value estimates on Alkane Resources - why the stock might be worth over 9x more than the current price!
Don't just follow the ticker - dig into the data and build a conviction that's truly your own.
Right now could be the best entry point. These picks are fresh from our daily scans. Don't delay:
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com